Combination therapy with a compound acting as a platelet ADP receptor inhibitor

Combination therapy with a compound acting as a platelet ADP receptor inhibitor

  • CN 101,686,959 B
  • Filed: 05/02/2008
  • Issued: 05/07/2014
  • Est. Priority Date: 05/02/2007
  • Status: Active Grant
First Claim
Patent Images

1. the first therapeutic component and the second therapeutic component are characterised in that the purposes in the medicine of unwelcome thrombotic disease preparation treatment mammal;

  • [4-(6-fluoro-7-methylamino-2 that wherein said the first therapeutic component is following formula;

    4-dioxo-Isosorbide-5-Nitrae-dihydro-2H-quinazoline-3-yl)-phenyl]-5-chloro-thiophene-2-base-sulfonylurea or its officinal salt;

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×